Johnson & Johnson’s JNJ -2.64% single-dose Covid-19 vaccine worked safely and should be authorized for use in the U.S., a panel of experts advised federal health regulators Friday. The advisory committee’s unanimous vote in support…
Day: December 27, 2018
J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA…
Johnson & Johnson’s JNJ -2.64% single-dose Covid-19 vaccine worked safely and should be authorized for use in the U.S., a panel of experts advised federal health regulators Friday. The advisory committee’s unanimous vote in support…